EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alterations in purine and pyrimidine metabolism associated with latent tuberculosis infection: insights from gut microbiome and metabolomics analyses

Boyi Yang iD, Xiaojing Guo, Chongyu Shi, Gang Liu, Xiaoling Qin, Shiyi Chen, Li Gan, Dongxu Liang, Kai Shao, Ruolan Xu, Jieqing Zhong, Yujie Mo und 2 weitere

mSystems · 19.11.2024 · 9 (11)

DOI: 10.1128/msystems.00812-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSystems, erschienen am 19.11.2024. Verfasst von Boyi Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, School of Public Health and Management, Guangxi University of Chinese Medicine, Nanning, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Latent Tuberculosis, Purines, Metabolomics. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: | Natural Science Foundation of Guangxi Zhuang Autonomous Region (Guangxi Natural Science Foundation), High Level Talent Cultivation and Innovation Project of Guangxi University of Chinese Medicine, Guangxi University of Chinese Medicine-Shenzhen Kangtai Biological Products Co.Ltd. Guangxi Hepatitis B Prevention and Control Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individuals with latent tuberculosis infection (LTBI) account for almost 30% of the population worldwide and have the potential to develop active tuberculosis (ATB). Despite this, the current understanding of the pathogenesis of LTBI is limited. The gut microbiome can be altered in tuberculosis patients, and an understanding of the changes associated with the progression from good health to LTBI to ATB can provide novel perspectives for understanding the pathogenesis of LTBI by identifying microbial and molecular biomarkers associated therewith. In this study, fecal samples from healthy controls (HC), individuals with LTBI and ATB patients were collected for gut microbiome and metabolomics analyses. Compared to HC and LTBI subjects, participants with ATB showed a significant decrease in gut bacterial α-diversity. Additionally, there were significant differences in gut microbial communities and metabolism among the HC, LTBI, and ATB groups. PICRUSt2 analysis revealed that microbiota metabolic pathways involving the degradation of purine and pyrimidine metabolites were upregulated in LTBI and ATB individuals relative to HCs. Metabolomic profiling similarly revealed that purine and pyrimidine metabolite levels were decreased in LTBI and ATB samples relative to those from HCs. Further correlation analyses revealed that the levels of purine and pyrimidine metabolites were negatively correlated with those of gut microbial genera represented by Ruminococcus_gnavus_group ( R. gnavus ), and the levels of R. gnavus were also positively correlated with adenosine nucleotide degradation II, which is a purine degradation pathway. Moreover, a combined signature including hypoxanthine and xanthine was found to effectively distinguish between LTBI and HC samples (area under the curve [AUC] of training set = 0.796; AUC of testing set = 0.924). Therefore, through gut microbiome and metabolomic analyses, these findings provide valuable clues regarding how alterations in gut purine and pyrimidine metabolism are linked to the pathogenesis of LTBI. IMPORTANCE This study provides valuable insight into alterations in the gut microbiome and metabolomic profiles in a cohort of adults with LTBI and ATB. Perturbed gut purine and pyrimidine metabolism in LTBI was associated with the compositional alterations of gut microbiota, which may be an impetus for developing novel diagnostic strategies and interventions targeting LTBI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeLatent TuberculosisPurinesMetabolomicsPyrimidinesHumansMaleAdultFemaleMiddle AgedFeces

Stichwörter der Autor:innen

active tuberculosisgut microbiomelatent tuberculosis infectionmetabolomicspurine metabolismpyrimidine metabolism

Substanzen

PurinesPyrimidinespyrimidinepurine

Autor:innen und Institutionen

  • Department of Biostatistics, School of Public Health and Management, Guangxi University of Chinese Medicine, Nanning, China.
  • Department of Physiology, School of Basic Medical Sciences, Guangxi Medical University, Nanning, China.
  • The First Clinical College, Guangxi Medical University, Nanning, China.
  • Molecular Biology Laboratory of Respiratory Disease, College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
  • Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, Nanning, China.

ORCID-Profile: Boyi Yang, Hai Li, Dan Luo

Förderung

  • | Natural Science Foundation of Guangxi Zhuang Autonomous Region (Guangxi Natural Science Foundation)
  • High Level Talent Cultivation and Innovation Project of Guangxi University of Chinese Medicine
  • Guangxi University of Chinese Medicine-Shenzhen Kangtai Biological Products Co.Ltd. Guangxi Hepatitis B Prevention and Control Project
  • Guangxi University of Chinese Medicine Guipai Xinglin Outstanding Talent Project
  • 广西壮族自治区科学技术厅 | Natural Science Foundation of Guangxi Zhuang Autonomous Region

Zitieren

APA

Yang, B., Guo, X., Shi, C., Liu, G., Qin, X., Chen, S., Gan, L., Liang, D., Shao, K., Xu, R., Zhong, J., Mo, Y., Li, H., & Luo, D. (2024). Alterations in purine and pyrimidine metabolism associated with latent tuberculosis infection: insights from gut microbiome and metabolomics analyses. mSystems, 9(11). https://doi.org/10.1128/msystems.00812-24

Vancouver

Yang B, Guo X, Shi C, Liu G, Qin X, Chen S, et al. Alterations in purine and pyrimidine metabolism associated with latent tuberculosis infection: insights from gut microbiome and metabolomics analyses. mSystems. 2024;9(11). doi:10.1128/msystems.00812-24

BibTeX
@article{Yang2024,
  author = {Yang, Boyi and Guo, Xiaojing and Shi, Chongyu and Liu, Gang and Qin, Xiaoling and Chen, Shiyi and Gan, Li and Liang, Dongxu and Shao, Kai and Xu, Ruolan and Zhong, Jieqing and Mo, Yujie and Li, Hai and Luo, Dan},
  title = {Alterations in purine and pyrimidine metabolism associated with latent tuberculosis infection: insights from gut microbiome and metabolomics analyses},
  journal = {mSystems},
  year = {2024},
  volume = {9},
  number = {11},
  doi = {10.1128/msystems.00812-24}
}
Kostenlos starten →